SOAT1 and Alzheimer disease: Since the JAK/STAT signaling pathway is involved in extracellular cytokine-activated receptor-mediated signal transduction, associated with cellular proliferation and differentiation, organ development, and immune homeostasis, it may be a potential target treatment in various neurodegenerative diseases, including Alzheimer’s disease.